These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14614019)

  • 1. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
    Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
    Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Zhu LX; Yu WC; Lo CM; Fan ST; Wong J
    Ann Surg; 2001 Feb; 233(2):227-35. PubMed ID: 11176129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma.
    Liu S; Wei Y; Nie L; Tang Z; Lu Q; Liang Q
    BMC Cancer; 2024 May; 24(1):614. PubMed ID: 38773427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic molecular markers in hepatocellular carcinoma.
    Qin LX; Tang ZY
    World J Gastroenterol; 2002 Jun; 8(3):385-92. PubMed ID: 12046056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability and manifestations of angiogenesis in stage IV of sporadic colorectal carcinoma.
    Otto W; Macrae F; Sierdziński J; Smaga J; Król M; Wilińska E; Zieniewicz K
    Medicine (Baltimore); 2019 Jan; 98(1):e13956. PubMed ID: 30608431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.
    He J; Zeng X; Wang C; Wang E; Li Y
    MedComm (2020); 2024 Aug; 5(8):e671. PubMed ID: 39070179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor pathway-related biomarkers in liver cancer: activated factor VII-antithrombin complex and tissue factor mRNA levels are associated with mortality.
    Martinelli N; Moruzzi S; Udali S; Castagna A; Di Santo L; Ambrosani F; Baroni M; Pattini P; Pizzolo F; Ruzzenente A; Conci S; Grusse M; Campagnaro T; Van Dreden P; Guglielmi A; Bernardi F; Olivieri O; Friso S
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102310. PubMed ID: 38282902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.
    Ahmadi SE; Shabannezhad A; Kahrizi A; Akbar A; Safdari SM; Hoseinnezhad T; Zahedi M; Sadeghi S; Mojarrad MG; Safa M
    Biomark Res; 2023 Jun; 11(1):60. PubMed ID: 37280670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review.
    Li X; Cao D; Zheng X; Wang G; Liu M
    Ann Transl Med; 2022 Nov; 10(22):1250. PubMed ID: 36544632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor: a neglected role in cancer biology.
    Li H; Yu Y; Gao L; Zheng P; Liu X; Chen H
    J Thromb Thrombolysis; 2022 Jul; 54(1):97-108. PubMed ID: 35763169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue.
    AlZaim I; Al-Saidi A; Hammoud SH; Darwiche N; Al-Dhaheri Y; Eid AH; El-Yazbi AF
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Dynamics of Coagulation and Angiogenesis Markers in Cancer Patients During and After Chemotherapy.
    Beleva EA; Deneva TI; Stoencheva SS; Grudeva-Popova ZG
    Clin Appl Thromb Hemost; 2021; 27():10760296211056637. PubMed ID: 34918975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.
    Zhang XP; Zhou TF; Feng JK; Sun ZY; Zhen ZJ; Zhou D; Zhang F; Hu YR; Zhong CQ; Chen ZH; Chai ZT; Wang K; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
    Front Oncol; 2021; 11():697073. PubMed ID: 34395264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond thrombosis: the impact of tissue factor signaling in cancer.
    Unruh D; Horbinski C
    J Hematol Oncol; 2020 Jul; 13(1):93. PubMed ID: 32665005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor expression predicts outcome in children with neuroblastoma: A retrospective study.
    Sherief LM; Hassan TH; Zakaria M; Fathy M; Eshak EA; Bebars MA; Esh A
    Oncol Lett; 2019 Dec; 18(6):6347-6354. PubMed ID: 31807159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
    Hisada Y; Mackman N
    Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.
    Hu Z
    Antibodies (Basel); 2018 Mar; 7(1):. PubMed ID: 31105982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis.
    Hisada Y; Mackman N
    Semin Thromb Hemost; 2019 Jun; 45(4):385-395. PubMed ID: 31096306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL).
    Hidaka H; Izumi N; Aramaki T; Ikeda M; Inaba Y; Imanaka K; Okusaka T; Kanazawa S; Kaneko S; Kora S; Saito H; Furuse J; Matsui O; Yamashita T; Yokosuka O; Morita S; Arioka H; Kudo M; Arai Y
    Med Oncol; 2019 May; 36(6):52. PubMed ID: 31053989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma.
    Huang SZ; Wei MN; Huang JR; Zhang ZJ; Zhang WJ; Jiang QW; Yang Y; Wang HY; Jin HL; Wang K; Xing ZH; Yuan ML; Li Y; He XS; Shi Z; Zhou Q
    Front Oncol; 2019; 9():150. PubMed ID: 30931258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.